Atlas Trials

Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin F(ab')2 Fragment (INM004) in Healthy Volunteers

Clinical trial NCT03388216 · COMPLETED

Trial details

NCT number
NCT03388216
Sponsor
Inmunova S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2017-12-16
Primary completion
2018-09-27
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.